private

近日,两家中概股公司——在线教育公司掌门教育,和在线营销服务公司爱点击——分别宣布达成私有化协议,分别从纽交所和纳斯达克退市。

掌门教育项目中,年利达担任公司董事会特别委员会的美国法律顾问,达维律师事务所则担任买方的美国律师。

掌门教育创办于2005年,于2014年转型为在线教育平台,并于20216月赴美上市。不过一年后,20226月,公司就因为市值过低被纽交所启动退市程序。本次私有化交易中,掌门教育创始人、董事会主席兼首席执行官张翼作为买方收购了其尚未实益拥有的该公司所有流通中的美国存托股份和普通股。

年利达常驻香港的公司业务部合伙人林晓希牵头主导了此次项目。

在爱点击项目中,佳利律师事务所单位特别委员会的美国律师,瑞格律师事务所、Prospera Law律师事务所则担任买方财团的美国法律顾问。

爱点击的主营业务是为广告主计划、投放及优化多渠道的广告投放,其于2017年在纳斯达克上市。本次交易中,公司与由内部人士组成的财团合并以进行私有化交易。交易预计将于2024年第一季度完成。

Linklaters, Davis Polk, Cleary, Ropes & Gray on two Chinese concept stock privatization deals

Two Chinese concept stock companies—online education company Zhangmen Education and online marketing services company iClick— have recently announced that they had reached privatization agreements to delist from the NYSE and Nasdaq, respectively.

In the Zhangmen Education project, Linklaters served as the US legal advisor to the company's special committee of the board of directors, while Davis Polk & Wardwell acted as the US attorney for the buyer.

Founded in 2005, Zhangmen Education transformed into an online education platform in 2014 and went public in the US in June 2021. However, a year later, in June 2022, the company was subjected to delisting procedures by the NYSE due to its low market value. In this privatization deal, Zhangmen's founder, board chairman, and CEO Zhang Yi, as the buyer, acquired all the circulating US depositary shares and ordinary shares of the company that he did not already beneficially own.

Lin Xiaoxi, a partner in Linklaters' Hong Kong corporate business department, led this project.

In the iClick project, Cleary Gottlieb Steen & Hamilton acted as the US attorney for the special committee, while Ropes & Gray and Prospera Law served as the US legal advisors for the buyer consortium.

iClick's main business is planning, delivering, and optimizing multi-channel advertising campaigns for advertisers. It went public on Nasdaq in 2017. In this transaction, the company merged with a consortium composed of company insiders to carry out the privatization deal. The transaction is expected to complete in the first quarter of 2024.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

礼德、富而德、凯易助力复宏汉霖54亿港元私有化交易(ZH/EN)

上海复星医药日前宣布,其控股子公司复星新药拟吸收合并及私有化港交所上市公司复宏汉霖。礼德律师事务所为复星提供服务;富而德律师事务所代表复宏汉霖参与交易;凯易国际律师事务所则为财务顾问中金公司提供法律意见。

港股私有化成2024年热点,律所专注提供上市公司“从进到退”全周期服务(ZH/EN)

2024年以来,私有化交易成为香港资本市场的一大亮点,这也为资本市场领域律师提供了新机遇。

高伟绅、司力达牵头赛生药业11.3亿美元私有化交易(ZH/EN)

近日,私募股权公司德福资本对港交所上市公司赛生药业提出私有化邀约。本次私有化交易通过协议安排方式实施,实施所需的现金总额约为 87.9 亿港元(约 为11.3 亿美元)。